BG64154B1 - Метод за получаване на хидроксамови киселини - Google Patents

Метод за получаване на хидроксамови киселини Download PDF

Info

Publication number
BG64154B1
BG64154B1 BG103319A BG10331999A BG64154B1 BG 64154 B1 BG64154 B1 BG 64154B1 BG 103319 A BG103319 A BG 103319A BG 10331999 A BG10331999 A BG 10331999A BG 64154 B1 BG64154 B1 BG 64154B1
Authority
BG
Bulgaria
Prior art keywords
aryl
heteroaryl
alkyl
alkoxy
solution
Prior art date
Application number
BG103319A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG103319A (en
Inventor
Joel M. Hawkins
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of BG103319A publication Critical patent/BG103319A/xx
Publication of BG64154B1 publication Critical patent/BG64154B1/bg

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08Hydroxylamino compounds or their ethers or esters
    • C07C239/14Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
BG103319A 1998-04-10 1999-04-09 Метод за получаване на хидроксамови киселини BG64154B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8136598P 1998-04-10 1998-04-10

Publications (2)

Publication Number Publication Date
BG103319A BG103319A (en) 2001-08-31
BG64154B1 true BG64154B1 (bg) 2004-02-27

Family

ID=22163686

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103319A BG64154B1 (bg) 1998-04-10 1999-04-09 Метод за получаване на хидроксамови киселини

Country Status (38)

Country Link
US (1) US6288246B1 (sh)
EP (1) EP0949244A3 (sh)
JP (1) JPH11343277A (sh)
KR (1) KR100329902B1 (sh)
CN (1) CN1232023A (sh)
AP (1) AP1203A (sh)
AR (1) AR018180A1 (sh)
AU (1) AU747629B2 (sh)
BG (1) BG64154B1 (sh)
BR (1) BR9901089A (sh)
CA (1) CA2268680A1 (sh)
CO (1) CO5070713A1 (sh)
DZ (1) DZ2757A1 (sh)
EA (1) EA002777B1 (sh)
EG (1) EG22263A (sh)
GT (1) GT199900046A (sh)
HR (1) HRP990105A2 (sh)
HU (1) HUP9901041A3 (sh)
ID (1) ID23337A (sh)
IL (1) IL129328A0 (sh)
IN (1) IN192342B (sh)
IS (1) IS5019A (sh)
MA (1) MA24831A1 (sh)
NO (1) NO991672L (sh)
NZ (1) NZ335104A (sh)
OA (1) OA11031A (sh)
PA (1) PA8469301A1 (sh)
PE (1) PE20000418A1 (sh)
PL (1) PL332450A1 (sh)
SG (1) SG125880A1 (sh)
SK (1) SK43699A3 (sh)
TN (1) TNSN99052A1 (sh)
TR (1) TR199900755A3 (sh)
TW (1) TW448147B (sh)
UA (1) UA57750C2 (sh)
UY (1) UY25460A1 (sh)
YU (1) YU18199A (sh)
ZA (1) ZA992631B (sh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
WO2004106319A1 (en) * 2003-05-30 2004-12-09 Pfizer Products Inc. Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide
US20070179293A1 (en) * 2003-08-29 2007-08-02 Basf Aktiengesellschaft Method for the production of o-substituted hydroxylamine compounds
EP3082996A4 (en) 2013-12-18 2017-07-05 Brita LP Container for filter-as-you-pour system
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Alk﹘5抑制劑和彼之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
CN1228083A (zh) 1996-08-23 1999-09-08 美国辉瑞有限公司 芳基磺酰氨基异羟肟酸衍生物
NZ336840A (en) 1997-02-03 2001-01-26 Pfizer Prod Inc Arylsulfonylamino hydroxamic acid derivatives useful in the treatment of tumor necrosis factor and matrix metalloproteinase mediated diseases
NZ502309A (en) 1997-08-08 2002-02-01 Pfizer Prod Inc Aryloxyarylsulfonylamino hydroxamic acid derivatives and pharmaceutical use
ES2176913T3 (es) 1997-08-08 2002-12-01 Pfizer Prod Inc Derivados de acidos arilsulfonilaminohidroxamicos.
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
PE20000418A1 (es) 2000-05-23
BR9901089A (pt) 2000-05-30
NZ335104A (en) 2000-10-27
EA199900284A3 (ru) 2000-04-24
SG125880A1 (en) 2006-10-30
HU9901041D0 (en) 1999-06-28
HUP9901041A3 (en) 2003-02-28
EP0949244A2 (en) 1999-10-13
AP1203A (en) 2003-09-05
PL332450A1 (en) 1999-10-11
CO5070713A1 (es) 2001-08-28
EA199900284A2 (ru) 1999-10-28
CA2268680A1 (en) 1999-10-10
HUP9901041A2 (hu) 2000-03-28
EP0949244A3 (en) 2001-05-30
IN192342B (sh) 2004-04-10
AU2369099A (en) 1999-10-21
TW448147B (en) 2001-08-01
GT199900046A (es) 2000-09-15
SK43699A3 (en) 2000-06-12
UA57750C2 (uk) 2003-07-15
EA002777B1 (ru) 2002-08-29
UY25460A1 (es) 1999-11-17
NO991672L (no) 1999-10-11
IS5019A (is) 1999-10-11
AR018180A1 (es) 2001-10-31
CN1232023A (zh) 1999-10-20
JPH11343277A (ja) 1999-12-14
ZA992631B (en) 2000-10-09
IL129328A0 (en) 2000-02-17
OA11031A (en) 2002-02-07
TR199900755A2 (xx) 1999-11-22
HRP990105A2 (en) 2000-02-29
US6288246B1 (en) 2001-09-11
MA24831A1 (fr) 1999-12-31
KR19990083051A (ko) 1999-11-25
BG103319A (en) 2001-08-31
AP9901503A0 (en) 1999-06-30
TNSN99052A1 (fr) 2005-11-10
NO991672D0 (no) 1999-04-09
ID23337A (id) 2000-04-05
EG22263A (en) 2002-11-30
DZ2757A1 (fr) 2003-09-15
AU747629B2 (en) 2002-05-16
YU18199A (sh) 2002-11-15
TR199900755A3 (tr) 1999-11-22
KR100329902B1 (ko) 2002-03-22
PA8469301A1 (es) 2000-09-29

Similar Documents

Publication Publication Date Title
BG64154B1 (bg) Метод за получаване на хидроксамови киселини
AP1095A (en) Process for alkylating hindered sulfonamides.
AP1155A (en) Process for preparing phenoxphenysulfonyl halides.
CZ122199A3 (cs) Způsob výroby hydroxamových kyselin
CZ20003735A3 (cs) Způsob alkylace bráněných sulfonamidů vhodných k přípravě inhibitorů matricové metaloproteinasy
MXPA00009903A (en) Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors